改善急性胸痛结局与效率的医疗模式:JACC最新综述
该综述指出,现有急性胸痛评估路径常资源密集、耗时且昂贵,并从患者和系统层面梳理了现有胸痛路径及问题。文章概述了胸痛研究的最新进展,包括高敏床旁肌钙蛋白检测、首诊前设备、人工智能与精准医学工具以及医院标杆管理策略,以期改善患者结局和卫生系统效率。
要点
- 现有急性胸痛评估路径资源密集、耗时且昂贵。
- 高敏床旁肌钙蛋白检测等新路径可改善风险分层。
- 人工智能与精准医学工具有助指导进一步检查指征。
核心结论
- 改善胸痛诊断与管理的速度及准确性应成为研究者优先事项,并可能为患者和卫生系统带来实质性获益。
研究设计与样本
- JACC最新综述,描述现有胸痛路径及患者与系统层面的当前问题,并概述胸痛研究最新进展。
主要发现
- 现有急性胸痛评估路径常资源密集、耗时且昂贵。
- 多种途径可改善现有胸痛照护模式,包括整合高敏床旁肌钙蛋白检测的新型风险分层路径。
- 首诊前可用的新设备能让临床医生获取生命体征和心电图数据。
- 人工智能和精准医学工具可能指导进一步检查的指征。
- 改善医院标杆管理和绩效监测的策略有助于标准化诊疗。
临床怎么用
- 可探索将高敏床旁肌钙蛋白检测整合入胸痛风险分层路径。
- 可利用首诊前设备获取生命体征和心电图数据以辅助早期评估。
- 可借助人工智能与精准医学工具指导进一步检查指征。
- 可通过医院标杆管理和绩效监测促进胸痛诊疗标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Existing assessment pathways for acute chest pain are often resource-intensive, prolonged, and expensive. In this review, the authors describe existing chest pain pathways and current issues at the patient and system level, and provide an overview of recent advances in chest pain research that could inform improved outcomes for both patients and health systems. There are multiple avenues to improve existing models of chest pain care, including novel risk stratification pathways incorporating highly sensitive point-of-care troponin assays; new devices available before first medical contact that could allow clinicians to access vital signs and electrocardiogram data; artificial intelligence and precision medicine tools that may guide indications for further testing; and strategies to improve hospital benchmarking and performance monitoring to standardize care. Improving the speed and accuracy of chest pain diagnosis and management should be a priority for researchers and is likely to translate to substantive benefits for patients and health systems.
引用
- Dawson, Smith, Cullen, et al. Care Models for Acute Chest Pain That Improve Outcomes and Efficiency: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 35680185. doi:10.1016/j.jacc.2022.03.380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。